Myomo (MYO) Notes Payables (2016 - 2025)
Myomo (MYO) posted Notes Payables of $999418.0 for Q4 2025, up 1180.57% on a QoQ basis from $78045.0 in Q3 2020.
Myomo (MYO) Notes Payables (2016 - 2025) Analysis & Trends
Myomo's Notes Payables history runs 6 years deep, the most recent figure standing at $999418.0 for Q4 2025.
- Quarterly Notes Payables changed N/A year-over-year to $999418.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $999418.0 (changed N/A YoY) and the FY2025 annual result came in at $999418.0, changed N/A from the prior year.
- Notes Payables was $999418.0 for Q4 2025 at Myomo, up from $78045.0 in the prior quarter.
- Across five years, Notes Payables topped out at $999418.0 in Q4 2025 and bottomed at $999418.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 999,418.00 |
| Sep 30, 2020 | 78,045.00 |
| Jun 30, 2020 | 996,841.00 |
| Mar 31, 2020 | 40,605.00 |
| Dec 31, 2019 | 378,239.00 |
| Sep 30, 2019 | 43,942.00 |
| Jun 30, 2019 | 58,477.00 |
| Mar 31, 2019 | 157,927.00 |
| Dec 31, 2018 | 3,661.00 |
| Sep 30, 2018 | 8,652.00 |
| Jun 30, 2018 | 21,962.00 |
| Mar 31, 2018 | 24,623.00 |
| Dec 31, 2017 | 39,930.00 |
| Sep 30, 2017 | 92,359.00 |
| Dec 31, 2016 | 876,458.00 |